Cargando…

Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy

OBJECTIVE: To explore themes underlying why anticoagulants are under-prescribed for stroke prevention in atrial fibrillation (AF) patients from the clinician’s perspective and characteristics of those patients. METHODS: Clinicians at the University of Utah Health system were recruited for semi-struc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Catherine, Jones, Aubrey E., Slager, Stacey, Fagerlin, Angela, Witt, Daniel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194321/
https://www.ncbi.nlm.nih.gov/pubmed/37213758
http://dx.doi.org/10.1016/j.pecinn.2022.100062
_version_ 1785043992584388608
author Yao, Catherine
Jones, Aubrey E.
Slager, Stacey
Fagerlin, Angela
Witt, Daniel M.
author_facet Yao, Catherine
Jones, Aubrey E.
Slager, Stacey
Fagerlin, Angela
Witt, Daniel M.
author_sort Yao, Catherine
collection PubMed
description OBJECTIVE: To explore themes underlying why anticoagulants are under-prescribed for stroke prevention in atrial fibrillation (AF) patients from the clinician’s perspective and characteristics of those patients. METHODS: Clinicians at the University of Utah Health system were recruited for semi-structured 15-minute interviews. An interview guide focused on anticoagulant prescribing practices for patients with AF. Interviews were transcribed verbatim. Two reviewers independently coded passages corresponding with key themes. RESULTS: Eleven practitioners were interviewed from cardiology, internal medicine, and family practice. Five themes were found: the role of compliance in anticoagulation decision making, the role of pharmacists in supporting clinicians, the use of shared decision making and risk communication, risk of bleeding as the main barrier to taking anticoagulants, and the variety of reasons patients have for not starting or discontinuing anticoagulants. CONCLUSION: Fear of bleeding was the foremost reason underlying anticoagulant underutilization in patients with AF followed by compliance, and patient worries. Communication between patients and clinicians as well as interdisciplinary teamwork are key to understanding and improving anticoagulant prescribing in AF. INNOVATION: Our study was the first to assess the role pharmacists play in prescribing clinician’s decisions surrounding anticoagulant use in AF. Pharmacists could play an important collaborative role in SDM.
format Online
Article
Text
id pubmed-10194321
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101943212023-05-19 Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy Yao, Catherine Jones, Aubrey E. Slager, Stacey Fagerlin, Angela Witt, Daniel M. PEC Innov Full length article OBJECTIVE: To explore themes underlying why anticoagulants are under-prescribed for stroke prevention in atrial fibrillation (AF) patients from the clinician’s perspective and characteristics of those patients. METHODS: Clinicians at the University of Utah Health system were recruited for semi-structured 15-minute interviews. An interview guide focused on anticoagulant prescribing practices for patients with AF. Interviews were transcribed verbatim. Two reviewers independently coded passages corresponding with key themes. RESULTS: Eleven practitioners were interviewed from cardiology, internal medicine, and family practice. Five themes were found: the role of compliance in anticoagulation decision making, the role of pharmacists in supporting clinicians, the use of shared decision making and risk communication, risk of bleeding as the main barrier to taking anticoagulants, and the variety of reasons patients have for not starting or discontinuing anticoagulants. CONCLUSION: Fear of bleeding was the foremost reason underlying anticoagulant underutilization in patients with AF followed by compliance, and patient worries. Communication between patients and clinicians as well as interdisciplinary teamwork are key to understanding and improving anticoagulant prescribing in AF. INNOVATION: Our study was the first to assess the role pharmacists play in prescribing clinician’s decisions surrounding anticoagulant use in AF. Pharmacists could play an important collaborative role in SDM. Elsevier 2022-06-30 /pmc/articles/PMC10194321/ /pubmed/37213758 http://dx.doi.org/10.1016/j.pecinn.2022.100062 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full length article
Yao, Catherine
Jones, Aubrey E.
Slager, Stacey
Fagerlin, Angela
Witt, Daniel M.
Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy
title Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy
title_full Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy
title_fullStr Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy
title_full_unstemmed Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy
title_short Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy
title_sort exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy
topic Full length article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194321/
https://www.ncbi.nlm.nih.gov/pubmed/37213758
http://dx.doi.org/10.1016/j.pecinn.2022.100062
work_keys_str_mv AT yaocatherine exploringclinicianperspectivesonpatientswithatrialfibrillationwhoarenotprescribedanticoagulationtherapy
AT jonesaubreye exploringclinicianperspectivesonpatientswithatrialfibrillationwhoarenotprescribedanticoagulationtherapy
AT slagerstacey exploringclinicianperspectivesonpatientswithatrialfibrillationwhoarenotprescribedanticoagulationtherapy
AT fagerlinangela exploringclinicianperspectivesonpatientswithatrialfibrillationwhoarenotprescribedanticoagulationtherapy
AT wittdanielm exploringclinicianperspectivesonpatientswithatrialfibrillationwhoarenotprescribedanticoagulationtherapy